Auriculasin
Auriculasin is an anticancer agent that inhibits VEGFR2, PI3K/AKT/mTOR, MAPK. Auriculasin can inhibit cell proliferation, induce cell apoptosis, and inhibit angiogenesis, and promotes mitochondrial oxidative stress and ferroptosis. Auriculasin is also active at the cannabinoid receptor CB1 with an IC50 of 8.92 μM. Auriculasin can be used in cancer research, especially related diseases such as prostate cancer and non-small cell lung cancer, as well as research on the development of anti-angiogenic drugs[1][2][3][4][5].
Product Specifications
CAS Number
60297-37-2
UNSPSC
12352005
Target
Akt; Cannabinoid Receptor; Ferroptosis; mTOR; p38 MAPK; PI3K; VEGFR
Type
Natural Products
Related Pathways
Apoptosis; GPCR/G Protein; MAPK/ERK Pathway; Neuronal Signaling; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/auriculasin.html
Purity
99.1
Solubility
10 mM in DMSO
Smiles
O=C1C(C(O)=C(C=CC(C)(C)O2)C2=C3C/C=C(C)\C)=C3OC=C1C4=CC=C(O)C(O)=C4
Molecular Formula
C25H24O6
Molecular Weight
420.45
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
CB1; VEGFR2/KDR/Flk-1
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![2-(2-Aminoethyl)-3',6'-bis(diethylamino)spiro[isoindoline-1,9'-xanthen]-3-one (>80%)](https://cdn.genprice.uk/products/572/7299255348304/imageurl/trc-a622790-50mg.webp)
2-(2-Aminoethyl)-3',6'-bis(diethylamino)spiro[isoindoline-1,9'-xanthen]-3-one (>80%)
TTF-1 / NKX2.1 (Thyroid & Lung Epithelial Marker) (NX2.1/1855R), CF740 conjugate, 0.1mg/mL
SARS-CoV-2 (COVID-19) S protein RBD (L452R), His Tag
